Files and links (1)
CC BY-NC-ND V4.0, Open Access
Editorial
Canagliflozin lowers blood sugar, but does it also lower cardiovascular risk? Maybe not
Annals of translational medicine, Vol.5(23), pp.473-473
12/01/2017
PMID: 29285506
Abstract
For the last 25 years it has been widely accepted that diabetes mellitus is associated with a twofold or greater risk of clinical atherosclerotic disease. Long-standing elevated blood sugar levels, as measured by the hemoglobin A1c level, have been shown to be independent of major cardiovascular risk factors including age, body mass index, systolic blood pressure, serum cholesterol, cigarette smoking, or history of cardiovascular disease.
Metrics
1 File views/ downloads
5 Record Views
Details
- Title
- Canagliflozin lowers blood sugar, but does it also lower cardiovascular risk? Maybe not
- Creators
- Thomas F. Heston - Washington State University, Elson S. Floyd College of MedicineAnndres H. Olson - Washington State University SpokaneNicholas R. Randall - Washington State University Spokane
- Publication Details
- Annals of translational medicine, Vol.5(23), pp.473-473
- Academic Unit
- Elson S. Floyd College of Medicine
- Publisher
- AME PUBLISHING COMPANY
- Number of pages
- 3
- Identifiers
- 99901107739901842
- Language
- English
- Resource Type
- Editorial